Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Daniel Bottomly, Nicola Long, Fei Yang, MD, Tiffany Lee, MD, Uma Borate, MD, Beth Wilmot, PhD, Adam S DuVall, MD, Andrea Monteblanco, BS, Karina Thiel-Klare, Gabby Dewson, BA, Richard D. Press, MD PhD, Cristina E. Tognon, Brian J. Druker, Jeffrey W. Tyner, Shannon K. McWeeney, PhD, Anupriya Agarwal, PhD

Blood (2019) 134 (Supplement_1): 1407.

https://doi.org/10.1182/blood-2019-132224

Published: 2019

Journal Articles

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

Tracy Murphy, MDFRCP,FRCPath, Stanley W.K. Ng, PhD, Tong Zhang, Ian King, PhD, Andrea Arruda, Jaime O. Claudio, PhD, Narmin Ibrahimova, Fiona Ferrera, Chantal Rockwell, Zhibin Lu, Natalie Stickle, Carl Virtanen, MSc, Brian Leber, MD, Mitchell Sabloff, MD, Mark D. Minden, MD PhD, Tracy L. Stockley, PhD FCCMG, FACMG, Steven M Chan, MD PhD, Jean C.Y. Wang, MD

Blood (2019) 134 (Supplement_1): 2682.

https://doi.org/10.1182/blood-2019-130532

Published: 2019

Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Kelly J. Norsworthy, MD, Xin Gao, PhD, Chia-Wen Ko, PhD, Jiaxi Zhou, MS, Yutao Gong, PhD, Yuan Li Shen, PhD, Rajeshwari Sridhara, PhD, Albert B. Deisseroth, MD PhD, Ann T. Farrell, MD, Richard Pazdur, MD, Gideon Blumenthal, MD

Blood (2018) 132 (Supplement 1): 2670.

https://doi.org/10.1182/blood-2018-99-119678

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Genomic-DNA Exposed By Somatic Gene Mutations Engages the cGAS/STING Axis to License the NLRP3 Inflammasome in Myelodysplastic Syndromes

Amy F McLemore, M.S., Kathy L McGraw, PhD, Hsin-An Hou, MD PhD, Grace A Ward, BS, Alexis H Onimus, BS, Nicole D. Vincelette, PhD, Matthew A. Rodrigues, PhD, Neelkamal Chaudhary, PhD, Ling Zhang, MD, Benjamin S. Meyer, Erika A Eksioglu, PhD MS, Sheng Wei, MD, Alan F. List, MD

Blood (2018) 132 (Supplement 1): 3075.

https://doi.org/10.1182/blood-2018-99-116929

Published: 2018

Journal Articles

Unbiased Profiling of the Immunomodulatory Properties of Soluble Proteins

Nikolaus Krall, PhD, Gregory Ian Vladimer, PhD, Berend Snijder, PhD, Noemi Meszaros, Nicole Müller-Sienerth, PhD, Gavin Wright, Giulio Superti-Furga, PhD

Blood (2017) 130 (Supplement 1): 2293.

https://doi.org/10.1182/blood.V130.Suppl_1.2293.2293

Published: 2017

Journal Articles

Does Treatment Satisfaction Influence Adherence to Treatment?: Impact of AF Patients' Treatment Satisfaction on Adherence to Oral Anticoagulation Treatment

Sabrina Mueller, Anna-Katharina Meinecke, Sandra Buchwald, Daniel Eriksson, Thomas Wilke

Blood (2017) 130 (Supplement 1): 2142.

https://doi.org/10.1182/blood.V130.Suppl_1.2142.2142

Published: 2017

Journal Articles

Real-World Adherence to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation: Results of an International Survey

Sabrina Mueller, Anna-Katharina Meinecke, Sandra Buchwald, Daniel Eriksson, Thomas Wilke

Blood (2017) 130 (Supplement 1): 4726.

https://doi.org/10.1182/blood.V130.Suppl_1.4726.4726

Published: 2017

Journal Articles

BCL11B Is a Key Regulator of T-Lineage Differentiation during the Initial Stages of Human Thymopoiesis

Vi Luan Ha, PhD, Annie Luong, Fan Li, David Casero, Jemily Malvar, MS, Ravi Bhatia, MD, Gay M Crooks, Chintan Parekh, MBBS

Blood (2016) 128 (22): 2657.

https://doi.org/10.1182/blood.V128.22.2657.2657

Published: 2016

Journal Articles

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

Matthias Eyrich, PhD, MD, Johannes Rachor, Marissa Blume, Isabelle Becker, Anne Stumpf, Harald Wajant, PhD, Matthias Wolfl, MD, Paul G. Schlegel, MD, Manfred Lutz, PhD

Blood (2013) 122 (21): 4726.

https://doi.org/10.1182/blood.V122.21.4726.4726

Published: 2013

Journal Articles

KIR Ligation During Ex Vivo Expansion Allows Molding Of The KIR Repertoire

Dean A. Lee, MD, PhD, Vladimir V Senyukov, PhD, Jerome R Trembley

Blood (2013) 122 (21): 2288.

https://doi.org/10.1182/blood.V122.21.2288.2288

Published: 2013

Journal Articles

KIR3DL1 and HLA-Bw4 Allotypes Predict The Extent Of NK Cell Licensing

Jeanette E Boudreau, BSc, PhD, Jean-Benoit Le Luduec, BSc, MSc, PhD, Katharine C. Hsu, MD, PhD

Blood (2013) 122 (21): 1043.

https://doi.org/10.1182/blood.V122.21.1043.1043

Published: 2013

Journal Articles

Natural Killer Cell Licensing Delineates NK “Helper/Repair” and NK “Effector/Suppressor” Subsets During Viral Infections

Can M. Sungur, Anthony E. Zamora, Ethan G. Aguilar, Yajarayma Tang-Feldman, Juan Du, Nicole Baumgarth, Mingyi Chen, MD, PhD, Claire Pomeroy, Jeffrey M. Venstrom, MD, William J. Murphy, PhD

Blood (2013) 122 (21): 13.

https://doi.org/10.1182/blood.V122.21.13.13

Published: 2013

Journal Articles

Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses

Can M. Sungur, Yajarayma J. Tang-Feldman, Anthony E. Zamora, Maite Alvarez, Claire Pomeroy, William J. Murphy

Blood (2013) 122 (8): 1518–1521.

https://doi.org/10.1182/blood-2013-02-483503

Published: 2013

Includes: Supplemental data

Journal Articles

Experience with Long-Term Lenalidomide (LEN) Treatment in the Clinical Setting: Results From the UK Revlimid ® Treatment Continuation Scheme™ (TCS)

Cathy D. Williams, MBBS, MCRP, FRCPath, Mathew Simcock, MSc, Imran Lodhi, MBBS, Suzanne K. Robinson, PhD, Faith E. Davies, MD

Blood (2012) 120 (21): 4067.

https://doi.org/10.1182/blood.V120.21.4067.4067

Published: 2012

Journal Articles

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Kai Sun, Maite Alvarez, Erik Ames, Isabel Barao, Mingyi Chen, Dan L. Longo, Doug Redelman, William J. Murphy

Blood (2012) 119 (6): 1590–1598.

https://doi.org/10.1182/blood-2011-08-374314

Published: 2012

Includes: Supplemental data

Journal Articles

Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin

Clare L. Bennett, Farnaz Fallah-Arani, Thomas Conlan, Celine Trouillet, Hugh Goold, Laurent Chorro, Barry Flutter, Terry K. Means, Frédéric Geissmann, Ronjon Chakraverty

Blood (2011) 117 (26): 7063–7069.

https://doi.org/10.1182/blood-2011-01-329185

Published: 2011

Includes: Supplemental data

Journal Articles

Unlicensed natural born killers

Andreas Lundqvist, Richard Childs

Blood (2011) 117 (26): 6974–6975.

https://doi.org/10.1182/blood-2011-05-350314

Published: 2011

Journal Articles

The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

Dimitrios Mougiakakos, Regina Jitschin, C. Christian Johansson, Riki Okita, Rolf Kiessling, Katarina Le Blanc

Blood (2011) 117 (18): 4826–4835.

https://doi.org/10.1182/blood-2010-12-324038

Published: 2011

Journal Articles

Interferon gamma licensing of human dendritic cells in T-helper–independent CD8 + alloimmunity

Roxane Lemoine, Florence Velge-Roussel, Florence Herr, Romain Felix, Hubert Nivet, Yvon Lebranchu, Christophe Baron

Blood (2010) 116 (16): 3089–3098.

https://doi.org/10.1182/blood-2010-02-268623

Published: 2010

NARROW

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Genomic-DNA Exposed By Somatic Gene Mutations Engages the cGAS/STING Axis to License the NLRP3 Inflammasome in Myelodysplastic Syndromes

Unbiased Profiling of the Immunomodulatory Properties of Soluble Proteins

Does Treatment Satisfaction Influence Adherence to Treatment?: Impact of AF Patients' Treatment Satisfaction on Adherence to Oral Anticoagulation Treatment

Real-World Adherence to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation: Results of an International Survey

BCL11B Is a Key Regulator of T-Lineage Differentiation during the Initial Stages of Human Thymopoiesis

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

KIR Ligation During Ex Vivo Expansion Allows Molding Of The KIR Repertoire

KIR3DL1 and HLA-Bw4 Allotypes Predict The Extent Of NK Cell Licensing

Natural Killer Cell Licensing Delineates NK “Helper/Repair” and NK “Effector/Suppressor” Subsets During Viral Infections

Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses

Experience with Long-Term Lenalidomide (LEN) Treatment in the Clinical Setting: Results From the UK Revlimid ® Treatment Continuation Scheme™ (TCS)

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin

Unlicensed natural born killers

The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

Interferon gamma licensing of human dendritic cells in T-helper–independent CD8 + alloimmunity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only